[2-(4-Benzyl-phenoxy)-ethyl]-diethyl-amine

ID: ALA26424

Cas Number: 98774-23-3

PubChem CID: 108092

Product Number: D350282, Order Now?

Max Phase: Phase

Molecular Formula: C19H25NO

Molecular Weight: 283.41

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Synonyms: Tesmilifene | Tesmilifene|98774-23-3|2-(4-benzylphenoxy)-N,N-diethylethanamine|DPPE|Tesmilifene [INN]|N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine|Depmpe|CHEMBL26424|I43T3ID6G2|DTXSID1045661|n,n-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine|N,N-DIETHYL-2-[4-BENZYLPHENOXY]ETHANAMINE|Ethanamine, N,N-diethyl-2-(4-(phenylmethyl)phenoxy)-|NCGC00024762-02|DTXCID9025661|UNII-I43T3ID6G2|CAS-98774-23-3|Ethanamine, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-|YMB1002|Tocris-0743|TESMILIFENE [MI]|2-((alphShow More

Synonyms from Alternative Forms(8): Tesmilifene hcl | Tesmilifene hydrochloride | BMS-217380-01 | BMY-33419 | DPP-E | DPPE | NSC-741196 | NSC-76285

Canonical SMILES:  CCN(CC)CCOc1ccc(Cc2ccccc2)cc1

Standard InChI:  InChI=1S/C19H25NO/c1-3-20(4-2)14-15-21-19-12-10-18(11-13-19)16-17-8-6-5-7-9-17/h5-13H,3-4,14-16H2,1-2H3

Standard InChI Key:  NFIXBCVWIPOYCD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -1.1208   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8333   -0.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1542    0.3583    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3000    0.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4083   -0.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1333    0.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3042   -0.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4208    0.7458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5458   -0.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0125    0.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7292    0.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4375    0.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8667    0.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1625   -0.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5500    0.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2625   -0.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5875    0.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8792   -0.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9833   -0.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2625    0.7333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9833    0.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3 12  1  0
  4  8  1  0
  5  1  2  0
  6  1  1  0
  7  5  1  0
  8  6  2  0
  9  2  1  0
 10  4  1  0
 11 10  1  0
 12 11  1  0
 13  3  1  0
 14  3  1  0
 15  9  1  0
 16  9  2  0
 17 13  1  0
 18 14  1  0
 19 16  1  0
 20 15  2  0
 21 19  2  0
  7  4  2  0
 20 21  1  0
M  END

Alternative Forms

  1. Parent:

  2. Alternative Forms:

Associated Targets(Human)

EBP Tchem Anti-estrogen binding site (AEBS) (124 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LTA4H Tchem Leukotriene A4 hydrolase (1442 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTT Tchem Huntingtin (19182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX15B Tchem Arachidonate 15-lipoxygenase, type II (7244 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GMNN Tbio Geminin (128009 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Esr1 Estrogen receptor (1901 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ffp 4'-phosphopantetheinyl transferase ffp (24982 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
lef Anthrax lethal factor (7585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 283.41Molecular Weight (Monoisotopic): 283.1936AlogP: 4.00#Rotatable Bonds: 8
Polar Surface Area: 12.47Molecular Species: BASEHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.33CX LogP: 4.64CX LogD: 2.72
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.73Np Likeness Score: -0.91

References

1. Teo CC, Kon OL, Sim KY, Ng SC..  (1992)  Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.,  35  (8): [PMID:1573630] [10.1021/jm00086a002]
2. Penning TD, Chandrakumar NS, Chen BB, Chen HY, Desai BN, Djuric SW, Docter SH, Gasiecki AF, Haack RA, Miyashiro JM, Russell MA, Yu SS, Corley DG, Durley RC, Kilpatrick BF, Parnas BL, Askonas LJ, Gierse JK, Harding EI, Highkin MK, Kachur JF, Kim SH, Krivi GG, Villani-Price D, Pyla EY, Smith WG..  (2000)  Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.,  43  (4): [PMID:10691697] [10.1021/jm990496z]
3. PubChem BioAssay data set, 
4. PubChem BioAssay data set, 
5. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
6. PubChem BioAssay data set, 
7. PubChem BioAssay data set, 
8. PubChem BioAssay data set, 
9. Unpublished dataset, 
10. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek.  (2020)  Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection,  [10.21203/rs.3.rs-23951/v1]
11. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani.  (2020)  Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen,  [10.6019/CHEMBL4495564]
12. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen.  (2020)  Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort,  [10.6019/CHEMBL4495565]
13. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]
14. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius.  (2021)  HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators,  [10.6019/CHEMBL4808148]